Cytotoxic Tph subset with low B-cell helper functions and its involvement in systemic lupus erythematosus

Noriyasu Seki,Hideto Tsujimoto,Shuhei Tanemura,Shinji Kojima,Fumihiko Miyoshi,Jun Kikuchi,Shuntaro Saito,Mitsuhiro Akiyama,Kunio Sugahara,Keiko Yoshimoto,Yuko Kaneko,Kenji Chiba,Tsutomu Takeuchi

DOI: https://doi.org/10.1038/s42003-024-05989-x

IF: 6.548

2024-03-07

Communications Biology

Abstract:T peripheral helper (Tph) cells are thought to contribute to extra-follicular B cell activation and play a pathogenic role in autoimmune diseases. However, the role of Tph subsets is not fully elucidated. Here, we investigate the immunological functions of Tph subsets and their involvement in systemic lupus erythematosus (SLE). We have defined four Tph subsets (Tph1: CXCR3 + CCR6 − , Tph2: CXCR3 − CCR6 − , Tph17: CXCR3 − CCR6 + , and Tph1-17: CXCR3 + CCR6 + ) and performed RNA sequencing after cell sorting. Tph1 and Tph17 subsets express substantial levels of IL21 , indicating B cell helper functions. However, Tph2 and Tph1-17 subsets express low IL21 . Interestingly, we have found Tph2 subset express high levels of CX3CR1 , GZMB , PRF1, GLNY , S1PR5, TBX21, EOMES , ZNF863 , and RUNX3 , indicating a feature of CD4 + cytotoxic T lymphocytes. In SLE patients, the frequency of Tph1 and Tph2 subsets are significantly increased and positively correlated with SLE disease activity indexes. Tph1 cells expansion has been observed in patients with cutaneous and musculoskeletal manifestations. On the other hand, Tph2 cell expansion has been found in patients with lupus nephritis in addition to the above manifestations. Our findings imply that Tph1 and Tph2 subsets exert distinct immunological functions and are contributed to the complexity of clinical manifestations in SLE.

biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the immunological functions of different subsets of Tph (T follicular helper cells) in systemic lupus erythematosus (SLE) and their relationships with clinical manifestations. Specifically, the researchers defined four Tph subsets (Tph1: CXCR3+CCR6−, Tph2: CXCR3−CCR6−, Tph17: CXCR3−CCR6+, and Tph1 - 17: CXCR3+CCR6+), and analyzed the gene expression patterns of these subsets through RNA sequencing. The study found that the Tph1 and Tph17 subsets expressed higher levels of IL21, indicating that they have B - cell - helper functions; while the Tph2 and Tph1 - 17 subsets expressed lower levels of IL21. In particular, the Tph2 subset expressed high - level genes such as CX3CR1, GZMB, PRF1, showing cytotoxic characteristics. In addition, the study also explored the frequency changes of Tph1 and Tph2 subsets in SLE patients and their correlations with disease activity indices (such as SLEDAI). The results showed that the frequencies of Tph1 and Tph2 subsets were significantly increased in SLE patients and were positively correlated with the disease activity of SLE. Further analysis showed that the expansion of Tph1 cells was related to skin and musculoskeletal manifestations, while the expansion of Tph2 cells was related to lupus nephritis in addition to the above manifestations. Through these studies, the authors aim to reveal the specific action mechanisms of different Tph subsets in SLE and how they affect the clinical manifestations of the disease, thereby providing new targets and strategies for the treatment of SLE.

Cytotoxic Tph subset with low B-cell helper functions and its involvement in systemic lupus erythematosus

Pd-1(+)Cxcr5(-)Cd4(+)T Cells Are Correlated With The Severity Of Systemic Lupus Erythematosus

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Tph Cells Expanded in Primary Sjögren’s Syndrome

Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus

Longitudinal analysis at pre- and post-flare of T peripheral helper and T follicular helper subsets in patients with systemic lupus erythematosus

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

T Follicular Helper Cells and Regulatory B Cells Dynamics in Systemic Lupus Erythematosus.

TLR4+CXCR4+ Plasma Cells Drive Nephritis Development in Systemic Lupus Erythematosus

T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis

Activation of circulating TFH17 cells associated with activated naive and double negative 2 B cell expansion, and disease activity in systemic lupus erythematosus patients

Follicular Helper T Cells in Systemic Lupus Erythematosus: a Potential Therapeutic Target.

Cytotoxic CD161−CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus

Circulating TIGIT±PD1+TPH, TIGIT ± PD1+TFH cells are elevated and their predicting role in systemic lupus erythematosus

Th22, but not Th17 Might be a Good Index to Predict the Tissue Involvement of Systemic Lupus Erythematosus

Associations of Circulating CXCR3–PD-1+CD4+T Cells with Disease Activity of Systemic Lupus Erythematosus

T peripheral helper cells in autoimmune diseases: What do we know?

[Role of Circulating T Follicular Helper Subsets and T Follicular Helper Effector Memory Cells in Systemic Lupus Erythematosus].

The conserved T cell receptor repertoire observed in patients with systemic lupus erythematosus

The Expression of Bcl-6 in Circulating Follicular Helper-Like T Cells Positively Correlates with the Disease Activity in Systemic Lupus Erythematosus.